Share

    


Home / Search Results

Search Results

Search Publications

Search Again?

Filter By Content Type

Filter By Topic

Copy of Wyoming talk 8_2023 9/25/23 1 1CONFIDENTIAL & PROPRIETARY THE PROMISE OF MULTI-CANCER EARLY DETECTION CLINICAL OVERVIEW JORDAN J KARLITZ MD, SENIOR MEDICAL DIRECTOR, MEDICAL AFFAIRS 1 CONFIDENTIAL & PROPRIETARY 2 Disclosures Employee of GRAIL, LLC, a subsidiary of Illumina, Inc, with equity in the company. 2 9/25/23 2 CONFIDENTIAL …
September 28, 2023
Now available is a 30-minute eCourse for members of the multidisciplinary cancer care team on how to use consistent, evidence-based health literacy best practices as it relates to lung cancer biomarker testing. Complete “Health Literacy Best Practices for Lung Cancer Biomarkers” to gain a lexicon of health terminology that resonates with patients and their caregivers and access downloadable resources …
THE VALUE OF FINANCIAL ADVOCACY ASSOCIATION OF COMMUNITY CANCER CENTERS The Challenge In the United States, cancer is one of the most expensive diseases to treat, and patients with cancer have a higher financial burden than those with other chronic conditions.1,2 Despite the increase in the number of insured patients, people are paying more out-of-pocket costs for care due …
ASSOCIATION OF COMMUNITY CANCER CENTERS EHR Integration: Effective Practices to Facilitate Timely and Comprehensive Biomarker Testing LANDSCAPE ANALYSIS Developing a Health Literacy and Clear Communications e-Course 2 EHR INTEGRATION: EFFECTIVE PRACTICES TO FACILITATE TIMELY AND COMPREHENSIVE BIOMARKER TESTING TABLE OF CONTENTS Executive Summary 3 Introduction …
Prior authorization remains one of the most discussed barriers to timely quality cancer care delivery among health care providers. The burden placed on the multidisciplinary care team to submit authorizations, complete peer-to-peer interviews, and fight appeals is extraordinary. In 2023, the Association of Community Cancer Centers (ACCC) conducted a survey of its membership examining …
September 27, 2023
Explore the impact of ACCC’s quality improvement initiative on several ovarian cancer care programs and learn about the ovarian quality of care self-assessment tool.
Survey Sweepstakes Official Rules 1. NO PURCHASE NECESSARY. OPEN ONLY TO LEGAL RESIDENTS OF THE UNITED STATES OF AMERICA WHO ARE AT LEAST 18 YEARS OLD AND A MEDICAL PROVIDER AT TIME OF ENTRY. Void where prohibited by law. This sweepstakes begins on October 4, 2023 at 12:01 a.m. ET and ends on October 6, 2023 11:59 pm ET (“Promotion Period”). Sponsor’s computer is the official time keeping …
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells Guideline ASTCT Consensus Neurologic Toxici Daniel W. Lee1,#, Bianc Jennifer N. Brudno6, M Lamis Eldjerou11, Rebe 16 o , S nc al an Un tc Im M l S rize the severity of these toxicities. The goal is to provide a uniform consensus grading system for CRS and neurotoxicity …
ASSOCIATION OF COMMUNITY CANCER CENTERS Examining the Financial Aspects of Cancer Biomarker Testing for Prior Authorizations TIP: Confused about these terms? Cancer care programs can follow the recommendations out- lined on commoncancertestingterms.org when discussing biomarker testing. TIP: Do not confuse genomic testing (tumor vari- ant) with genetic testing (inherited …
Let’s Win Pancreatic Cancer provides a road map of resources to help newly diagnosed patients with pancreatic cancer obtain the resources they need throughout their care journey.
September 23, 2023
Collaboration is key to driving innovative solutions and ideas to support quality care delivery. Come collaborate with your peers at the Texas Society of Clinical Oncology (TxSCO) 2023 Annual Conference and take advantage of this complimentary CE program. Join prominent oncology researchers, industry insiders, and legislative experts in a setting designed to maximize discussions on topics that matter …
September 22, 2023
You're invited to participate in Targeted Oncology's Community Case Forum the evening before the TxSCO 2023 Annual Conference on Friday, September 22nd at 3 pm at the Hyatt Regency Frisco- Dallas. Attend a case-based discussion on Myeloproliferative Neoplasms: Myelofibrosis and Polycythemia vera (MPN) or Extensive-Stage Small Cell Lung Cancer (SCLC) led by expert moderators following a networking …
September 22, 2023
In this workshop, provided by the France Foundation, interactive formats will allow the multidisciplinary care team to continuously assess knowledge gaps.
Updates in Metastatic Breast Cancer treatment Ajit K Bisen, MD, MBA Dept of General Oncology Dept of Breast Medical Oncology UT MD Anderson Cancer Center Disclosures Advisory Board/Consulting • Gilead 4/2023 • Biotheranostics 5/2023 Globally, 684996 deaths and over 2.3 million cases of breast cancer last year Stage IV Regional Localized …
Texas Society of Clinical Oncology Annual Conference 2023 Presented By: Laith Abushahin MBBS @LAbushahin Updates in Gastrointestinal Malignancies Laith Abushahin MBBS Texas Oncology Baylor Charles A Sammons Cancer Center Dallas, Texas Gastrointestinal Malignancies 2023 estimates: • ~ 340 k new Cases. ~ 166 k deaths in 2023 in USA.1 • ~ 12,260 cancer deaths out of …
Building Meaningful Diversity, Equity, and Inclusivity into Oncology Practice Dr. Richard Lewis Martin III, MD, MPH (he/him/his) Medical Director, Health Equity and Community Engagement Tennessee Oncology President: ACCC - Tennessee Oncology Practice Society (TOPS) Disclosures • Funding • U54 CA0914010 (NCI) • 09/01/2021-08/31/2025 • Meharry-Vanderbilt-TSU Cancer Partnership …
Genetic Companion Testing in Oncology The Importance of Genetic Counseling and Testing For Hereditary Cancer Syndromes Gayle Patel, MS, CGC Texas Oncology About Me I have no disclosures Importance of Diagnosis of Hereditary Cancer Syndromes Enhanced Surveillance Treatment Options Cascade Testing …
Managing CAR T Cell Toxicity: Strategies and Insights Sai Ravi Pingali MD Associate Professor of Clinical Medicine Houston Methodist Hospital 09/23/2023 Conflict of Interests Attended Ad Board of Cardinal Health From Bench to Bedside: The History and Progress of CAR T Cell Therapy. Mitra A. et. al. Frontiers in Immunology. May 2023. Approved CAR T TherapiesApproved …
Assessing the prevalence and current trends in the use of cannabidiol (CBD) products in patient with active malignancy Krishna Suthar, MD1 krishna.suthar@bswhealth.org Jess Hatfield, BS2 Patricia Meyer, PharmD2 Lucas Wong, MD1 1Division of Hematology & Medical Oncology, Department of Internal Medicine Baylor Scott and White - Temple 2Texas A&M School of Medicine, …